Hassani Salah-Eddine, Wolfram Roswitha M, Kuchulakanti Pramod K, Xue Zhenyi, Gevorkian Natalie, Suddath William O, Satler Lowell F, Kent Kenneth M, Pichard Augusto D, Weissman Neil J, Waksman Ron
Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, DC 20010, USA.
Catheter Cardiovasc Interv. 2006 Jul;68(1):36-43. doi: 10.1002/ccd.20768.
We aimed to compare clinical outcomes of octogenarians > or =80 years of age after coronary drug-eluting stent (DES) implantation.
Although octogenarians constitute a fast-growing portion of cardiovascular patients, they are not adequately represented in current clinical revascularization trials.
We analyzed the data of 3,166 consecutive patients who underwent percutaneous coronary intervention (PCI) and DES implantation since March 2003. Periprocedural events, 1- and 6-month clinical outcomes were compared between octogenarians (n = 339) and patients <80 years of age (n = 2,827).
Baseline characteristics revealed a higher prevalence of females (P < 0.001), Caucasians (P = 0.004), chronic renal failure (P < 0.001), heart failure (P < 0.001), number of diseased vessels (P = 0.009), and lower ejection fraction (P = 0.03) in octogenarians. Patients <80 years showed more positive family history (P < 0.001), hyperlipidemia (P = 0.006), smoking (P < 0.001), and obesity (P < 0.001). Clinical presentation and procedural success were similar in both groups as were death, myocardial infarction (MI), and repeat revascularization in-hospital. At 6 months, restenosis rates were low and comparable. In the subgroup of octogenarians who presented with acute coronary syndrome, mortality (15% vs. 3%, P < 0.001) and Q-wave MI occurred more often. Multivariate analysis revealed age >80 (P = 0.008), cardiogenic shock (P < 0.001), Q-wave MI at presentation (P = 0.003), and length of hospital stay (P = 0.003) to be independent predictors of mortality.
PCI with DES in octogenarians results in a similar reduction of restenosis rates when compared to patients <80 years. Yet in octogenarians who presented with acute coronary syndrome, incidence of mortality and Q-wave MI at 6 months was higher as compared to younger patients.
我们旨在比较年龄≥80岁的高龄患者冠状动脉药物洗脱支架(DES)植入术后的临床结局。
尽管高龄患者在心血管疾病患者中所占比例迅速增长,但在当前的临床血运重建试验中,他们的代表性不足。
我们分析了自2003年3月以来连续3166例接受经皮冠状动脉介入治疗(PCI)和DES植入术患者的数据。比较了高龄患者(n = 339)和年龄<80岁患者(n = 2827)的围手术期事件、1个月和6个月的临床结局。
基线特征显示,高龄患者中女性(P < 0.001)、白种人(P = 0.004)、慢性肾衰竭(P < 0.001)、心力衰竭(P < 0.001)、病变血管数量(P = 0.009)的患病率更高,射血分数更低(P = 0.03)。年龄<80岁的患者有更多的阳性家族史(P < 0.001)、高脂血症(P = 0.006)、吸烟(P < 0.001)和肥胖(P < 0.001)。两组的临床表现和手术成功率相似,住院期间的死亡、心肌梗死(MI)和再次血运重建情况也相似。在6个月时,再狭窄率较低且相当。在出现急性冠状动脉综合征的高龄患者亚组中,死亡率(15%对3%,P < 0.001)和Q波MI更常发生。多因素分析显示,年龄>80岁(P = 0.008)、心源性休克(P < 0.001)、就诊时Q波MI(P = 0.003)和住院时间(P = 0.003)是死亡的独立预测因素。
与年龄<80岁的患者相比,高龄患者PCI联合DES治疗导致的再狭窄率降低相似。然而,在出现急性冠状动脉综合征的高龄患者中,6个月时的死亡率和Q波MI发生率高于年轻患者。